3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:千円) |
| 前連結会計年度 (2025年6月30日) | 当連結会計年度 (2026年6月30日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 1,738,317 | 2,041,081 |
受取手形 | 264 | 118 |
売掛金 | 247,461 | 274,887 |
販売用不動産 | 823,691 | 2,287,197 |
仕掛販売用不動産 | 1,550,832 | 1,371,750 |
商品及び製品 | 39,413 | 35,048 |
仕掛品 | 47,484 | 46,995 |
原材料及び貯蔵品 | 90,380 | 133,997 |
営業貸付金 | 824,947 | 1,100,000 |
前払費用 | 466,295 | 492,556 |
その他 | 136,061 | 257,680 |
貸倒引当金 | △293,642 | △993,151 |
流動資産合計 | 5,671,507 | 7,048,162 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 2,330,709 | 2,400,994 |
減価償却累計額 | △1,373,405 | △1,486,826 |
建物及び構築物(純額) | 957,304 | 914,168 |
機械装置及び運搬具 | 232,443 | 270,523 |
減価償却累計額 | △154,414 | △163,585 |
機械装置及び運搬具(純額) | 78,028 | 106,937 |
土地 | 738,302 | 798,424 |
リース資産 | 674,407 | 752,020 |
減価償却累計額 | △308,837 | △306,900 |
リース資産(純額) | 365,569 | 445,120 |
建設仮勘定 | 8,069 | 2,509 |
その他 | 521,335 | 556,939 |
減価償却累計額 | △417,152 | △429,290 |
その他(純額) | 104,183 | 127,648 |
有形固定資産合計 | 2,251,457 | 2,394,808 |
無形固定資産 | | |
その他 | 26,205 | 13,642 |
無形固定資産合計 | 26,205 | 13,642 |
投資その他の資産 | | |
投資有価証券 | 54,472 | 38,692 |
長期貸付金 | 26,785 | 21,470 |
敷金及び保証金 | 403,531 | 410,141 |
繰延税金資産 | 186,560 | 207,455 |
その他 | 110,433 | 97,669 |
投資その他の資産合計 | 781,783 | 775,430 |
固定資産合計 | 3,059,446 | 3,183,881 |
資産合計 | 8,730,954 | 10,232,043 |
| | (単位:千円) |
| 前連結会計年度 (2025年6月30日) | 当連結会計年度 (2026年6月30日) |
負債の部 | | |
流動負債 | | |
買掛金 | 745,256 | 1,599,050 |
短期借入金 | 1,499,000 | 3,195,000 |
1年内返済予定の長期借入金 | 836,735 | 1,267,746 |
1年内償還予定の社債 | 300,000 | - |
リース債務 | 132,355 | 160,081 |
未払法人税等 | 60,927 | 47,224 |
資産除去債務 | - | 12,900 |
株主優待引当金 | 29,190 | 34,333 |
契約負債 | 130,805 | 158,851 |
その他 | 560,556 | 703,360 |
流動負債合計 | 4,294,826 | 7,178,548 |
固定負債 | | |
社債 | 100,000 | 100,000 |
長期借入金 | 2,259,053 | 1,586,179 |
リース債務 | 291,363 | 352,345 |
繰延税金負債 | 425 | 82 |
退職給付に係る負債 | 119,047 | 120,167 |
株式給付引当金 | 28,786 | 27,734 |
資産除去債務 | 217,124 | 214,831 |
その他 | 202,471 | 198,160 |
固定負債合計 | 3,218,271 | 2,599,500 |
負債合計 | 7,513,098 | 9,778,049 |
純資産の部 | | |
株主資本 | | |
資本金 | 422,996 | 422,996 |
資本剰余金 | 220,914 | 233,456 |
利益剰余金 | 1,096,784 | 302,581 |
自己株式 | △521,213 | △506,996 |
株主資本合計 | 1,219,481 | 452,038 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | △1,625 | 1,955 |
その他の包括利益累計額合計 | △1,625 | 1,955 |
純資産合計 | 1,217,855 | 453,994 |
負債純資産合計 | 8,730,954 | 10,232,043 |
E2746432860トラストホールディングス株式会社TRUST Holdings Inc.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-07-012026-06-30FY2026-06-302024-07-012025-06-302025-06-301falsefalsefalse328602024-06-30jppfs_cor:RetainedEarningsMember328602024-06-30jppfs_cor:TreasuryStockMember328602024-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember328602026-06-30jpcrp_cor:ReportableSegmentsMember328602026-06-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember328602025-07-012026-06-30jpcrp_cor:ReportableSegmentsMember328602025-07-012026-06-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember328602025-06-30jpcrp_cor:ReportableSegmentsMember328602025-06-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember328602024-07-012025-06-30jpcrp_cor:ReportableSegmentsMember328602024-07-012025-06-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember328602026-06-30tse-acedjpfr-32860:ParkingReportableSegmentsMember328602026-06-30tse-acedjpfr-32860:PropertiesDevelopmentAndSalesReportableSegmentsMember328602026-06-30tse-acedjpfr-32860:SecuritiesRetailingBusinessReportableSegmentsMember328602026-06-30tse-acedjpfr-32860:RVReportableSegmentsMember328602025-07-012026-06-30tse-acedjpfr-32860:ParkingReportableSegmentsMember328602025-07-012026-06-30tse-acedjpfr-32860:PropertiesDevelopmentAndSalesReportableSegmentsMember328602025-07-012026-06-30tse-acedjpfr-32860:SecuritiesRetailingBusinessReportableSegmentsMember328602025-07-012026-06-30tse-acedjpfr-32860:MedicalReportableSegmentsMember328602025-07-012026-06-30tse-acedjpfr-32860:RVReportableSegmentsMember328602025-06-30tse-acedjpfr-32860:ParkingReportableSegmentsMember328602024-07-012025-06-30328602025-06-30tse-acedjpfr-32860:PropertiesDevelopmentAndSalesReportableSegmentsMember328602024-06-30jppfs_cor:CapitalSurplusMember328602024-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember328602026-06-30jppfs_cor:ShareholdersEquityMember328602026-06-30jppfs_cor:CapitalStockMember328602026-06-30jppfs_cor:CapitalSurplusMember328602026-06-30jppfs_cor:RetainedEarningsMember328602026-06-30jppfs_cor:TreasuryStockMember328602026-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember328602026-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember328602025-07-012026-06-30jppfs_cor:ShareholdersEquityMember328602025-07-012026-06-30jppfs_cor:CapitalStockMember328602025-07-012026-06-30jppfs_cor:CapitalSurplusMember328602025-07-012026-06-30jppfs_cor:RetainedEarningsMember328602025-07-012026-06-30jppfs_cor:TreasuryStockMember328602025-07-012026-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember328602025-07-012026-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember328602025-06-30jppfs_cor:ShareholdersEquityMember328602025-06-30jppfs_cor:CapitalStockMember328602025-06-30jppfs_cor:CapitalSurplusMember328602025-06-30jppfs_cor:RetainedEarningsMember328602025-06-30jppfs_cor:TreasuryStockMember328602025-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember328602026-06-30tse-acedjpfr-32860:MedicalReportableSegmentsMember328602025-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember328602024-07-012025-06-30jppfs_cor:ShareholdersEquityMember328602025-06-30tse-acedjpfr-32860:SecuritiesRetailingBusinessReportableSegmentsMember328602025-06-30tse-acedjpfr-32860:MedicalReportableSegmentsMember328602025-06-30tse-acedjpfr-32860:RVReportableSegmentsMember328602024-07-012025-06-30tse-acedjpfr-32860:ParkingReportableSegmentsMember328602024-07-012025-06-30tse-acedjpfr-32860:PropertiesDevelopmentAndSalesReportableSegmentsMember328602024-07-012025-06-30tse-acedjpfr-32860:SecuritiesRetailingBusinessReportableSegmentsMember328602024-07-012025-06-30tse-acedjpfr-32860:MedicalReportableSegmentsMember328602024-07-012025-06-30tse-acedjpfr-32860:RVReportableSegmentsMember328602026-06-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember328602026-06-30jpcrp_cor:ReconcilingItemsMember328602025-07-012026-06-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember328602025-07-012026-06-30jpcrp_cor:ReconcilingItemsMember328602025-06-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember328602025-06-30jpcrp_cor:ReconcilingItemsMember328602024-07-012025-06-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember328602024-07-012025-06-30jpcrp_cor:ReconcilingItemsMember328602024-06-30328602024-07-012025-06-30jppfs_cor:CapitalSurplusMember328602024-07-012025-06-30jppfs_cor:RetainedEarningsMember328602024-07-012025-06-30jppfs_cor:TreasuryStockMember328602024-07-012025-06-30jppfs_cor:ValuationAndTranslationAdjustmentsMember328602024-07-012025-06-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember328602024-06-30jppfs_cor:ShareholdersEquityMember328602024-06-30jppfs_cor:CapitalStockMember328602026-08-10328602026-06-30328602025-07-012026-06-30328602025-06-30328602024-07-012025-06-30jppfs_cor:CapitalStockMemberxbrli:pureiso4217:JPY